SK285446B6 - Spôsob výroby medziproduktu pri výrobe (-)-6-chlór-4- cyklopropyletinyl-4-trifluórmetyl-1,4-dihydro-2H-3,1-benzoxazin- 2-ónu - Google Patents

Spôsob výroby medziproduktu pri výrobe (-)-6-chlór-4- cyklopropyletinyl-4-trifluórmetyl-1,4-dihydro-2H-3,1-benzoxazin- 2-ónu Download PDF

Info

Publication number
SK285446B6
SK285446B6 SK1562-99A SK156299A SK285446B6 SK 285446 B6 SK285446 B6 SK 285446B6 SK 156299 A SK156299 A SK 156299A SK 285446 B6 SK285446 B6 SK 285446B6
Authority
SK
Slovakia
Prior art keywords
alkyl
chiral
conh
substituted
nhconh
Prior art date
Application number
SK1562-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK156299A3 (en
Inventor
Cheng Yi Chen
Richard D. Tillyer
Lushi Tan
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9711599A external-priority patent/GB9711599D0/en
Priority claimed from GB9727129A external-priority patent/GB9727129D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of SK156299A3 publication Critical patent/SK156299A3/sk
Publication of SK285446B6 publication Critical patent/SK285446B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SK1562-99A 1997-05-16 1998-05-12 Spôsob výroby medziproduktu pri výrobe (-)-6-chlór-4- cyklopropyletinyl-4-trifluórmetyl-1,4-dihydro-2H-3,1-benzoxazin- 2-ónu SK285446B6 (sk)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4671397P 1997-05-16 1997-05-16
GB9711599A GB9711599D0 (en) 1997-06-05 1997-06-05 Efficient enatioselective addition reation using an organozinc reagent
US5788497P 1997-09-03 1997-09-03
GB9727129A GB9727129D0 (en) 1997-12-22 1997-12-22 Efficient enantioselective addition reaction using an organozinc reagent
US8352598P 1998-04-29 1998-04-29
PCT/US1998/008888 WO1998051676A1 (en) 1997-05-16 1998-05-12 Efficient enantioselective addition reaction using an organozinc reagent

Publications (2)

Publication Number Publication Date
SK156299A3 SK156299A3 (en) 2000-07-11
SK285446B6 true SK285446B6 (sk) 2007-01-04

Family

ID=27547294

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1562-99A SK285446B6 (sk) 1997-05-16 1998-05-12 Spôsob výroby medziproduktu pri výrobe (-)-6-chlór-4- cyklopropyletinyl-4-trifluórmetyl-1,4-dihydro-2H-3,1-benzoxazin- 2-ónu

Country Status (26)

Country Link
US (1) US6015926A (xx)
EP (1) EP0981520B1 (xx)
JP (1) JP3273615B2 (xx)
KR (1) KR100566683B1 (xx)
CN (1) CN1106389C (xx)
AR (1) AR011731A1 (xx)
AT (1) ATE270666T1 (xx)
AU (1) AU739250B2 (xx)
BR (1) BR9809628A (xx)
CA (1) CA2289206C (xx)
CZ (1) CZ297968B6 (xx)
DE (1) DE69824958T2 (xx)
DK (1) DK0981520T3 (xx)
EA (1) EA002192B1 (xx)
ES (1) ES2224396T3 (xx)
HR (1) HRP980266B1 (xx)
HU (1) HU226881B1 (xx)
NZ (1) NZ500526A (xx)
PL (1) PL193448B1 (xx)
PT (1) PT981520E (xx)
RS (1) RS49860B (xx)
SI (1) SI0981520T1 (xx)
SK (1) SK285446B6 (xx)
TW (1) TWI221833B (xx)
UA (1) UA59396C2 (xx)
WO (1) WO1998051676A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201158B1 (en) * 1998-06-22 2001-03-13 Merck & Co., Inc. Process for making intermediate aldehydes
AU2005237520B2 (en) 2004-04-27 2012-01-19 Wyeth Purification of progesterone receptor modulators
US20090163601A1 (en) * 2007-12-21 2009-06-25 The Regents Of The University Of California (r)-2-methyl-(2,5-dimethylphenyl)propanol and (s)-(2-methyl-2,5-dimethylphenyl)propanol
ZA200806473B (en) * 2008-01-31 2009-04-29 Aptuit Laurus Pvt Ltd An efficient process to induce enantioselectivity in procarbonyl compounds
US9073817B2 (en) 2008-01-31 2015-07-07 Laurus Labs Private Limited Efficient process to induce enantioselectivity in procarbonyl compounds
EP2291362A1 (en) 2008-05-01 2011-03-09 Ranbaxy Laboratories Limited Process for the preparation of efavirenz
US8604189B2 (en) * 2008-05-30 2013-12-10 Emcure Pharmaceuticals Limited Process for the preparation of Efavirenz
KR100878436B1 (ko) * 2008-08-18 2009-01-13 주식회사 지씨에이치앤피 금은화 추출물을 포함하는 소화성 궤양 치료 또는 예방용 약학조성물
WO2010115640A1 (en) * 2009-04-09 2010-10-14 Lonza Ltd Process for the synthesis of cyclic carbamates
EP2417097A2 (en) * 2009-04-09 2012-02-15 Lonza Ltd. Autocatalytic process for the synthesis of chiral propargylic alcohols
WO2010115639A1 (en) * 2009-04-09 2010-10-14 Lonza Ltd Process for the synthesis of a propargylic alcohol
WO2010115641A1 (en) * 2009-04-09 2010-10-14 Lonza Ltd Process for the synthesis of chiral cyclic carbamates
EP2448917A2 (de) 2009-07-03 2012-05-09 Archimica GmbH Verfahren zur enantioselektiven addition von organometallischen kohlenstoffnukleophilen an trifluormethylketone und verwendung des verfahrens in der synthese von hiv reverse transcriptase inhibitoren
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
EP2447247A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of chiral propargylic alcohols
EP2441759A1 (en) * 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
WO2012079235A1 (en) * 2010-12-16 2012-06-21 Lonza Ltd Process for preparing efavirenz
CN103254087B (zh) * 2013-06-07 2015-03-18 郑州大学 依非韦伦中间体的制备方法
CN105330554B (zh) 2015-02-15 2017-07-11 上海迪赛诺药业股份有限公司 手性环丙基乙炔基叔醇类化合物的合成方法
DE202015104551U1 (de) 2015-08-27 2015-12-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Reaktoren für die Herstellung von Efavirenz sowie Zwischenprodukte
NL2018412B1 (en) 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz
CN106946718A (zh) * 2017-04-27 2017-07-14 武汉工程大学 一种合成依非韦伦中间体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663169A (en) * 1992-08-07 1997-09-02 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one
JP2000507970A (ja) * 1997-01-10 2000-06-27 メルク エンド カンパニー インコーポレーテッド キラルメディエータの効率的な合成
PL197740B1 (pl) * 1997-02-05 2008-04-30 Merck & Co Inc Postać krystaliczna I (-)-6-chloro-4-cyklopropyloetynylo-4-trifluorometylo-1,4-dihydro-2H-3,1-benzoksazyn-2-onu i sposób krystalizacji postaci I (-)-6-chloro-4-cyklopropylo-etynylo-4-trifluorometylo-1,4-dihydro-2H-3,1-benzoksazyn-2-onu
TW480253B (en) * 1997-02-12 2002-03-21 Merck & Co Inc Efficient synthesis of a 1,4-dihydro-2H-3,1-benzoxazin-2-one

Also Published As

Publication number Publication date
ES2224396T3 (es) 2005-03-01
SK156299A3 (en) 2000-07-11
CA2289206C (en) 2008-02-05
US6015926A (en) 2000-01-18
ATE270666T1 (de) 2004-07-15
HUP0003404A2 (hu) 2000-12-28
HRP980266B1 (en) 2002-10-31
JP3273615B2 (ja) 2002-04-08
NZ500526A (en) 2001-07-27
PT981520E (pt) 2004-10-29
EP0981520A1 (en) 2000-03-01
SI0981520T1 (en) 2004-10-31
CZ404699A3 (cs) 2000-07-12
CZ297968B6 (cs) 2007-05-09
HRP980266A2 (en) 1999-02-28
EA199901040A1 (ru) 2000-04-24
EP0981520B1 (en) 2004-07-07
DE69824958D1 (de) 2004-08-12
RS49860B (sr) 2008-08-07
YU58299A (sh) 2001-12-26
CA2289206A1 (en) 1998-11-19
DK0981520T3 (da) 2004-11-01
JP2000513746A (ja) 2000-10-17
HUP0003404A3 (en) 2003-06-30
PL336717A1 (en) 2000-07-03
TWI221833B (en) 2004-10-11
KR100566683B1 (ko) 2006-04-03
AU739250B2 (en) 2001-10-04
AU7470798A (en) 1998-12-08
DE69824958T2 (de) 2005-07-14
CN1255919A (zh) 2000-06-07
PL193448B1 (pl) 2007-02-28
AR011731A1 (es) 2000-08-30
WO1998051676A1 (en) 1998-11-19
KR20010012650A (ko) 2001-02-26
UA59396C2 (uk) 2003-09-15
HU226881B1 (en) 2010-01-28
CN1106389C (zh) 2003-04-23
BR9809628A (pt) 2000-07-04
EA002192B1 (ru) 2002-02-28

Similar Documents

Publication Publication Date Title
SK285446B6 (sk) Spôsob výroby medziproduktu pri výrobe (-)-6-chlór-4- cyklopropyletinyl-4-trifluórmetyl-1,4-dihydro-2H-3,1-benzoxazin- 2-ónu
JP4232911B2 (ja) ベンゾオキサジノン類の不斉合成
US6040480A (en) Asymmetric synthesis of benzoxazinones
CA3212491A1 (en) Synthesis of omecamtiv mecarbil
JP4157272B2 (ja) ２ｒ−［１−ヒドロキシ−１−トリフルオロメチル−３−シクロプロピルプロピン−２−イル］−４−クロロアニリンの光学純度を高める方法
US5952528A (en) Process for enhancing the optical purity
CZ2000801A3 (cs) Způsob zvýšení optické čistoty
US6018069A (en) 2-isoxazoline derivative and process for producing the same and process for producing related derivatives from the same
MXPA00002220A (en) Process for enhancing the optical purity of 2r-[1-hydroxy- 1-trifluoromethyl- 3 -cyclopropylpropyn- 2yl]-4-chloroaniline
JPH03176496A (ja) フェロセニル誘導体及びその利用
EA009659B1 (ru) Способ получения иминного промежуточного соединения

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20100203

PC4A Assignment and transfer of rights

Owner name: SCHERING CORPORATION, KENILWORTH, NEW JERSEY, US

Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20121122

TC4A Change of owner's name

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20121122

MK4A Patent expired

Expiry date: 20180512